| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.77B | 42.33B | 57.94B | 70.72B | 75.26B | 83.81B |
| Gross Profit | 6.85B | 7.83B | 11.44B | 12.05B | 13.61B | 13.31B |
| EBITDA | 20.02B | 9.43B | 9.51B | 11.36B | 37.38B | 29.69B |
| Net Income | 12.94B | 5.37B | 4.49B | 7.09B | 27.54B | 20.92B |
Balance Sheet | ||||||
| Total Assets | 256.30B | 149.94B | 126.61B | 89.02B | 89.84B | 74.63B |
| Cash, Cash Equivalents and Short-Term Investments | 13.68B | 20.83B | 28.06B | 20.72B | 25.77B | 21.41B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.79B |
| Total Liabilities | 66.77B | 31.70B | 23.94B | 14.49B | 22.41B | 24.58B |
| Stockholders Equity | 188.81B | 117.81B | 102.41B | 74.54B | 67.43B | 50.04B |
Cash Flow | ||||||
| Free Cash Flow | 4.04B | -6.03B | 7.05B | 295.32M | -1.48B | 4.49B |
| Operating Cash Flow | 5.91B | -3.73B | 8.16B | 1.24B | -195.28M | 5.51B |
| Investing Cash Flow | 14.79B | 3.59B | 214.06M | -5.52B | 20.02B | 17.02B |
| Financing Cash Flow | -18.46B | -7.51B | -5.39B | -1.74B | -16.53B | -18.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥148.52B | 11.09 | 1.86% | 0.76% | -16.19% | -50.21% | |
63 Neutral | $5.28T | -102.21 | -2.51% | 1.31% | -10.97% | -118.87% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥154.27B | -42.55 | ― | ― | -51.82% | -96.08% | |
49 Neutral | $1.15T | -31.31 | -4.26% | 2.30% | 0.04% | -323.26% | |
49 Neutral | ¥9.47B | -27.97 | ― | 1.86% | -7.54% | ― | |
45 Neutral | ¥19.23B | -12.69 | ― | 3.98% | -6.84% | 50.71% |